Coronary patency after intravenous infusion of recombinant tissue-type plasminogen activator in acute myocardial infarction
- 1 April 1988
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 11 (4) , 681-688
- https://doi.org/10.1016/0735-1097(88)90196-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rateThe American Journal of Cardiology, 1987
- DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Factors influencing probability of reperfusion with intracoronary ostial infusion of thrombolytic agent in patients with acute myocardial infarction.Circulation, 1985
- Effects of Intracoronary Streptokinase and Intracoronary Nitroglycerin Infusion on Coronary Angiographic Patterns and Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1984
- Obtaining Confidence Intervals for the Risk Ratio in Cohort StudiesPublished by JSTOR ,1978